2012
DOI: 10.1155/2012/212893
|View full text |Cite
|
Sign up to set email alerts
|

The Impact of Osteopontin Gene Variations on Multiple Sclerosis Development and Progression

Abstract: Osteopontin is a proinflammatory molecule, modulating TH1 and TH17 responses. Several reports suggest its involvement in multiple sclerosis (MS) pathogenesis. We previously reported that OPN gene variations at the 3′ end are a predisposing factor for MS development and evolution. In this paper, we extended our analysis to a gene variation at the 5′ end on the −156G > GG single nucleotide polymorphism (SNP) and replicated our previous findings at the 3′ end on the +1239A > C SNP. We found that only +1239A > C S… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
29
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 36 publications
(30 citation statements)
references
References 29 publications
1
29
0
Order By: Relevance
“…For its action in the regulation of immune system, OPN has been recognized to have a role in the development/progression of several autoimmune diseases, such as multiple sclerosis (16,17,18,19) rheumatoid arthritis (20,21), psoriasis (22) and Graves' disease (23).…”
Section: Introductionmentioning
confidence: 99%
“…For its action in the regulation of immune system, OPN has been recognized to have a role in the development/progression of several autoimmune diseases, such as multiple sclerosis (16,17,18,19) rheumatoid arthritis (20,21), psoriasis (22) and Graves' disease (23).…”
Section: Introductionmentioning
confidence: 99%
“…Caillier et al found that patients carrying at least one wild-type 1284 A/4 allele were less likely to have a mild disease course [2]. Hensiek et al found no effect of SNPs located in exons 6 and 7 of OPN on the clinical severity of MS [6], while Comi et al reported the role of OPN variation on MS development and progression; however, they did not discuss its effect on disease severity [4].…”
Section: Discussionmentioning
confidence: 99%
“…+1239A and −156/GG homozygosity was associated with slower disease progression. Moreover, patients homozygous for +1239A showed lower relapse rate than those carrying +1239C [61].…”
Section: Multiple Sclerosismentioning
confidence: 91%